Generative AI Workflow Cuts Regulatory Reporting Time by 4X for Leading RNAi Therapeutics Company
Key Highlights
4X Faster Turnaround: Slashed the time required to generate audit-ready Pre-IND safety dossiers from ~160 hours to just ~40 hours per molecule.
96% Factual Accuracy: Achieved near-perfect scientific accuracy and 97% citation quality in AI-generated summaries, verified through a rigorous "LLM-as-a-judge" framework.
Custom Agentic Workflows: Leveraged the Polly Platform to replace error-prone manual literature curation with autonomous, task-specific agents capable of deep scientific inference.
Zero Headcount Scaling: Enabled the regulatory and bioinformatics teams to support a rapidly growing pipeline of 20+ active therapeutic programs without adding staff.
Thank you for showing interest! You will receive the Case Study in your Mailbox shortly.
.svg)
.svg)
%201%20(1).svg)
.svg)
%201.svg){kind=icon}
.svg)
%20(1).svg)
